The current valuation score of Amphastar Pharmaceuticals Inc is 8.06, ranking 108 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 11.00, which is 180.42% below the recent high of 30.86 and 33.40% above the recent low of 7.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.